201 related articles for article (PubMed ID: 12771946)
1. A major role for Mcl-1 antiapoptotic protein in the IL-6-induced survival of human myeloma cells.
Jourdan M; Veyrune JL; De Vos J; Redal N; Couderc G; Klein B
Oncogene; 2003 May; 22(19):2950-9. PubMed ID: 12771946
[TBL] [Abstract][Full Text] [Related]
2. Regulation of Bcl-2-family proteins in myeloma cells by three myeloma survival factors: interleukin-6, interferon-alpha and insulin-like growth factor 1.
Jourdan M; De Vos J; Mechti N; Klein B
Cell Death Differ; 2000 Dec; 7(12):1244-52. PubMed ID: 11175262
[TBL] [Abstract][Full Text] [Related]
3. Delineation of the roles of paracrine and autocrine interleukin-6 (IL-6) in myeloma cell lines in survival versus cell cycle. A possible model for the cooperation of myeloma cell growth factors.
Jourdan M; Mahtouk K; Veyrune JL; Couderc G; Fiol G; Redal N; Duperray C; De Vos J; Klein B
Eur Cytokine Netw; 2005; 16(1):57-64. PubMed ID: 15809207
[TBL] [Abstract][Full Text] [Related]
4. The cyclin-dependent kinase inhibitor flavopiridol induces apoptosis in multiple myeloma cells through transcriptional repression and down-regulation of Mcl-1.
Gojo I; Zhang B; Fenton RG
Clin Cancer Res; 2002 Nov; 8(11):3527-38. PubMed ID: 12429644
[TBL] [Abstract][Full Text] [Related]
5. Mcl-1 mediates cytokine deprivation induced apoptosis of human myeloma cell line XG-7.
Song L; Li Y; Sun Y; Shen B
Chin Med J (Engl); 2002 Aug; 115(8):1241-3. PubMed ID: 12215301
[TBL] [Abstract][Full Text] [Related]
6. Cooperation between heparin-binding EGF-like growth factor and interleukin-6 in promoting the growth of human myeloma cells.
Wang YD; De Vos J; Jourdan M; Couderc G; Lu ZY; Rossi JF; Klein B
Oncogene; 2002 Apr; 21(16):2584-92. PubMed ID: 11971193
[TBL] [Abstract][Full Text] [Related]
7. IL-6-independent expression of Mcl-1 in human multiple myeloma.
Zhang B; Potyagaylo V; Fenton RG
Oncogene; 2003 Mar; 22(12):1848-59. PubMed ID: 12660820
[TBL] [Abstract][Full Text] [Related]
8. Activation of sphingosine kinase mediates suppressive effect of interleukin-6 on human multiple myeloma cell apoptosis.
Li QF; Wu CT; Duan HF; Sun HY; Wang H; Lu ZZ; Zhang QW; Liu HJ; Wang LS
Br J Haematol; 2007 Sep; 138(5):632-9. PubMed ID: 17686057
[TBL] [Abstract][Full Text] [Related]
9. The anti-apoptotic role of interleukin-6 in human cervical cancer is mediated by up-regulation of Mcl-1 through a PI 3-K/Akt pathway.
Wei LH; Kuo ML; Chen CA; Chou CH; Cheng WF; Chang MC; Su JL; Hsieh CY
Oncogene; 2001 Sep; 20(41):5799-809. PubMed ID: 11593385
[TBL] [Abstract][Full Text] [Related]
10. IFN-alpha is a survival factor for human myeloma cells and reduces dexamethasone-induced apoptosis.
Ferlin-Bezombes M; Jourdan M; Liautard J; Brochier J; Rossi JF; Klein B
J Immunol; 1998 Sep; 161(6):2692-9. PubMed ID: 9743325
[TBL] [Abstract][Full Text] [Related]
11. The imbalance between Bim and Mcl-1 expression controls the survival of human myeloma cells.
Gomez-Bougie P; Bataille R; Amiot M
Eur J Immunol; 2004 Nov; 34(11):3156-64. PubMed ID: 15459900
[TBL] [Abstract][Full Text] [Related]
12. Interferon alpha induces cell death through interference with interleukin 6 signaling and inhibition of STAT3 activity.
Thyrell L; Arulampalam V; Hjortsberg L; Farnebo M; Grandér D; Pokrovskaja Tamm K
Exp Cell Res; 2007 Nov; 313(19):4015-24. PubMed ID: 17880940
[TBL] [Abstract][Full Text] [Related]
13. Marrow stromal cells induce B7-H1 expression on myeloma cells, generating aggressive characteristics in multiple myeloma.
Tamura H; Ishibashi M; Yamashita T; Tanosaki S; Okuyama N; Kondo A; Hyodo H; Shinya E; Takahashi H; Dong H; Tamada K; Chen L; Dan K; Ogata K
Leukemia; 2013 Feb; 27(2):464-72. PubMed ID: 22828443
[TBL] [Abstract][Full Text] [Related]
14. Phosphatidylinositol 3-kinase is essential for kit ligand-mediated survival, whereas interleukin-3 and flt3 ligand induce expression of antiapoptotic Bcl-2 family genes.
Karlsson R; Engström M; Jönsson M; Karlberg P; Pronk CJ; Richter J; Jönsson JI
J Leukoc Biol; 2003 Nov; 74(5):923-31. PubMed ID: 12960281
[TBL] [Abstract][Full Text] [Related]
15. The RANK/RANK ligand system is involved in interleukin-6 and interleukin-11 up-regulation by human myeloma cells in the bone marrow microenvironment.
Giuliani N; Colla S; Morandi F; Rizzoli V
Haematologica; 2004 Sep; 89(9):1118-23. PubMed ID: 15377473
[TBL] [Abstract][Full Text] [Related]
16. The survival of IL-6-dependent myeloma cells critically relies on their capability to transit the G1 to S phase interval of the cell cycle.
Côté S; Lemieux R; Simard C
Cell Signal; 2005 May; 17(5):615-24. PubMed ID: 15683736
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-6 acts as an antiapoptotic factor in human esophageal carcinoma cells through the activation of both STAT3 and mitogen-activated protein kinase pathways.
Leu CM; Wong FH; Chang C; Huang SF; Hu CP
Oncogene; 2003 Oct; 22(49):7809-18. PubMed ID: 14586407
[TBL] [Abstract][Full Text] [Related]
18. Mcl-1 is overexpressed in multiple myeloma and associated with relapse and shorter survival.
Wuillème-Toumi S; Robillard N; Gomez P; Moreau P; Le Gouill S; Avet-Loiseau H; Harousseau JL; Amiot M; Bataille R
Leukemia; 2005 Jul; 19(7):1248-52. PubMed ID: 15902294
[TBL] [Abstract][Full Text] [Related]
19. Sphingosine 1-phosphate induces Mcl-1 upregulation and protects multiple myeloma cells against apoptosis.
Li QF; Wu CT; Guo Q; Wang H; Wang LS
Biochem Biophys Res Commun; 2008 Jun; 371(1):159-62. PubMed ID: 18423379
[TBL] [Abstract][Full Text] [Related]
20. Synergistic induction of oxidative injury and apoptosis in human multiple myeloma cells by the proteasome inhibitor bortezomib and histone deacetylase inhibitors.
Pei XY; Dai Y; Grant S
Clin Cancer Res; 2004 Jun; 10(11):3839-52. PubMed ID: 15173093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
